New drug trial targets Hard-to-Treat thyroid and salivary gland cancers
NCT ID NCT07521670
First seen Apr 19, 2026 · Last updated May 06, 2026 · Updated 2 times
Summary
This study tests a drug called sacituzumab tirumotecan in people whose adenoid cystic carcinoma (a rare salivary gland cancer) or papillary thyroid carcinoma has returned or spread. The goal is to see if the drug can shrink tumors. About 68 participants will receive the drug by IV twice a month. This is an early-phase trial, so the main focus is on safety and whether the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center Hospital
Tokyo, Japan
-
National Cancer Center Korea
Gyeonggi-do, South Korea
-
National Cancer Centre Singapore
Singapore, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarawak General Hospital
Kuching, Sarawak, Malaysia
-
Seoul National University Hospital
Seoul, South Korea
-
Tan Tock Seng Hospital
Singapore, Singapore
-
University of Malaya Medical Center
Kuala Lumpur, Malaysia
Conditions
Explore the condition pages connected to this study.